DOMZALSKI DAVID (President and CEO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/4/2024ACC: 0001415889-24-015370
DirectorOfficer· President and CEO
Since Mar 2020
+4.43K
Net shares
Net buyer
$9.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.43K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.43K
Price / share
$2.16
Trade value
$9.56K
% of position
0.9%
5/31/2024
494.16K→498.59K
Total
Net shares
+4.43K
Net value
$9.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2024 | A · Award | +4.43K | $2.16 | $9.56K | 0.9% | 494.16K | 498.59K |
| Total | +4.43K | $9.56K | ||||||
Derivative Transactions0
No derivative transactions reported